+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 3imd | ||||||
---|---|---|---|---|---|---|---|
タイトル | Crystal Structure of the Grb2 SH2 Domain in Complex with a Flexible Ac-pY-Q-N-NH2 Tripeptide Mimic | ||||||
要素 | Growth factor receptor-bound protein 2 | ||||||
キーワード | SIGNALING PROTEIN/PEPTIDE / ligand preorganization / peptide mimics / Golgi apparatus / Host-virus interaction / Phosphoprotein / SH2 domain / SIGNALING PROTEIN / SIGNALING PROTEIN-pseudopeptide ligand complex / SIGNALING PROTEIN-PEPTIDE COMPLEX | ||||||
機能・相同性 | 機能・相同性情報 guanyl-nucleotide exchange factor adaptor activity / Grb2-EGFR complex / branching involved in labyrinthine layer morphogenesis / STAT5 Activation / COP9 signalosome / neurotrophin TRKA receptor binding / Activated NTRK2 signals through PI3K / MET receptor recycling / transmembrane receptor protein tyrosine kinase adaptor activity / Signaling by cytosolic FGFR1 fusion mutants ...guanyl-nucleotide exchange factor adaptor activity / Grb2-EGFR complex / branching involved in labyrinthine layer morphogenesis / STAT5 Activation / COP9 signalosome / neurotrophin TRKA receptor binding / Activated NTRK2 signals through PI3K / MET receptor recycling / transmembrane receptor protein tyrosine kinase adaptor activity / Signaling by cytosolic FGFR1 fusion mutants / Interleukin-15 signaling / MET activates PTPN11 / MET activates RAP1 and RAC1 / vesicle membrane / Costimulation by the CD28 family / CD28 dependent Vav1 pathway / Signaling by LTK / MET activates PI3K/AKT signaling / Signal regulatory protein family interactions / natural killer cell mediated cytotoxicity / positive regulation of actin filament polymerization / epidermal growth factor receptor binding / Regulation of KIT signaling / PI-3K cascade:FGFR2 / PI-3K cascade:FGFR3 / STAT5 activation downstream of FLT3 ITD mutants / PI-3K cascade:FGFR4 / PI-3K cascade:FGFR1 / endodermal cell differentiation / regulation of MAPK cascade / GRB2:SOS provides linkage to MAPK signaling for Integrins / RHOU GTPase cycle / PI3K events in ERBB2 signaling / PI3K Cascade / RET signaling / SOS-mediated signalling / insulin receptor substrate binding / Activated NTRK3 signals through RAS / Interleukin-3, Interleukin-5 and GM-CSF signaling / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / fibroblast growth factor receptor signaling pathway / Signalling to RAS / signal transduction in response to DNA damage / RHO GTPases Activate WASPs and WAVEs / GAB1 signalosome / SHC-related events triggered by IGF1R / Activated NTRK2 signals through FRS2 and FRS3 / Role of LAT2/NTAL/LAB on calcium mobilization / Interleukin receptor SHC signaling / Signal attenuation / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / Schwann cell development / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / Erythropoietin activates RAS / Signaling by CSF3 (G-CSF) / SHC-mediated cascade:FGFR1 / FRS-mediated FGFR2 signaling / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / Signaling by FGFR2 in disease / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / Tie2 Signaling / FRS-mediated FGFR1 signaling / GRB2 events in EGFR signaling / FLT3 Signaling / SHC1 events in EGFR signaling / EGFR Transactivation by Gastrin / Signaling by FLT3 fusion proteins / phosphotyrosine residue binding / Signaling by FGFR1 in disease / myelination / ephrin receptor binding / GRB2 events in ERBB2 signaling / NCAM signaling for neurite out-growth / SHC1 events in ERBB2 signaling / Downstream signal transduction / Constitutive Signaling by Overexpressed ERBB2 / Insulin receptor signalling cascade / FCERI mediated Ca+2 mobilization / insulin-like growth factor receptor signaling pathway / T cell activation / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / InlB-mediated entry of Listeria monocytogenes into host cell / Antigen activates B Cell Receptor (BCR) leading to generation of second messengers / Regulation of signaling by CBL / cellular response to ionizing radiation / Negative regulation of FGFR2 signaling / FCGR3A-mediated phagocytosis / FCERI mediated MAPK activation / Negative regulation of FGFR3 signaling / B cell receptor signaling pathway / Signaling by ERBB2 TMD/JMD mutants / EGFR downregulation 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) | ||||||
手法 | X線回折 / 分子置換 / 解像度: 2 Å | ||||||
データ登録者 | Clements, J.H. | ||||||
引用 | ジャーナル: J.Am.Chem.Soc. / 年: 2009 タイトル: Thermodynamic and Structural Effects of Conformational Constraints in Protein-Ligand Interactions. Entropic Paradoxy Associated with Ligand Preorganization. 著者: Delorbe, J.E. / Clements, J.H. / Teresk, M.G. / Benfield, A.P. / Plake, H.R. / Millspaugh, L.E. / Martin, S.F. #1: ジャーナル: Angew.Chem.Int.Ed.Engl. / 年: 2006 タイトル: Ligand Preorganization May Be Accompanied by Entropic Penalties in Protein-Ligand Interactions 著者: Benfield, A.P. / Teresk, M.G. / Plake, H.R. / DeLorbe, J.E. / Millspaugh, L.E. / Martin, S.F. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 3imd.cif.gz | 63 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb3imd.ent.gz | 45 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 3imd.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 3imd_validation.pdf.gz | 1 MB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 3imd_full_validation.pdf.gz | 1 MB | 表示 | |
XML形式データ | 3imd_validation.xml.gz | 12.7 KB | 表示 | |
CIF形式データ | 3imd_validation.cif.gz | 17.6 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/im/3imd ftp://data.pdbj.org/pub/pdb/validation_reports/im/3imd | HTTPS FTP |
-関連構造データ
-リンク
-集合体
登録構造単位 |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
2 |
| ||||||||
3 |
| ||||||||
単位格子 |
|
-要素
#1: タンパク質 | 分子量: 13758.543 Da / 分子数: 2 / 断片: SH2 domain / 由来タイプ: 組換発現 / 詳細: Sequence was expressed with a C-terminal 6-his tag / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: GRB2, ASH / プラスミド: pQE-60 / 発現宿主: Escherichia coli (大腸菌) / 株 (発現宿主): SG13009 / 参照: UniProt: P62993 #2: 化合物 | #3: 化合物 | ChemComp-CL / #4: 化合物 | ChemComp-MG / | #5: 水 | ChemComp-HOH / | |
---|
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 1.789 Å3/Da / 溶媒含有率: 31.262 % |
---|---|
結晶化 | 温度: 298 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 8.5 詳細: Ligand in lyphilized powder form was dissolved in a 9.1 mg/mL solution of Grb2 SH2 in water such to give a protein/ligand molar ratio of 2:1. 3 uL of this solution was mixed with 4 uL of 0.2 ...詳細: Ligand in lyphilized powder form was dissolved in a 9.1 mg/mL solution of Grb2 SH2 in water such to give a protein/ligand molar ratio of 2:1. 3 uL of this solution was mixed with 4 uL of 0.2 M MgCl2 x 6H2O, 30% w/v PEG MW4000, 0.1 M TRIS, pH 8.5 to create the hanging drop, which yielded crystals of the protein-ligand complex in the presence of the above-mentioned solution after four weeks at room temperature., VAPOR DIFFUSION, HANGING DROP, temperature 298K |
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: 回転陽極 / タイプ: RIGAKU RU200 / 波長: 1.5418 Å |
検出器 | タイプ: RIGAKU RAXIS IV / 検出器: IMAGE PLATE / 日付: 2007年3月1日 |
放射 | モノクロメーター: blue max-flux confocal / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.5418 Å / 相対比: 1 |
反射 | 解像度: 1.79→50 Å / Num. all: 19302 / Num. obs: 18279 / % possible obs: 94.7 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / 冗長度: 5.9 % / Rmerge(I) obs: 0.049 / Χ2: 1.536 / Net I/σ(I): 50.8 |
反射 シェル | 解像度: 1.79→1.85 Å / 冗長度: 5.9 % / Rmerge(I) obs: 0.084 / Num. unique all: 1797 / Χ2: 1.85 / % possible all: 96.1 |
-位相決定
位相決定 | 手法: 分子置換 |
---|
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 分子置換 開始モデル: pdb entry 3C7I 解像度: 2→50 Å / Occupancy max: 1 / Occupancy min: 0.5 / 交差検証法: THROUGHOUT / σ(F): 0 / σ(I): 0 / 立体化学のターゲット値: Engh & Huber
| ||||||||||||||||||||||||||||||||||||
溶媒の処理 | Bsol: 11.411 Å2 | ||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso max: 99.99 Å2 / Biso mean: 11.313 Å2 / Biso min: 1 Å2
| ||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2→50 Å
| ||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||
Xplor file |
|